ChemFaces have 28 compounds are similar structure. Ganolucidic acid D (CAS#102607-22-7); Hainanic acid B (CAS#1637737-46-2); New compound 18 (CAS#N/A); New compound 20 (CAS#N/A); Ganolucidic acid A (CAS#98665-21-5); Ganolucidic acid B (CAS#98683-75-1); Ganoderic acid B (CAS#81907-61-1); Methyl ganoderate B (CAS#81907-65-5); Ganoderenic acid B (CAS#100665-41-6); Methyl ganoderenate B (CAS#N/A); (3beta,7beta,12beta,20Z)- 3,7,12- trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid (CAS#1961358-02-0); Ganoderic acid C2 (CAS#103773-62-2); Ganoderic acid A (CAS#81907-62-2); Methyl ganoderate A (CAS#105742-78-7); Methyl lucidenate G (CAS#102607-20-5); Ganoderic acid C1 (CAS#95311-97-0); Ganoderic acid LM2 (CAS#508182-41-0); Ganoderenic acid G (CAS#120481-73-4); Ganoderic acid J (CAS#100440-26-4); Ganoderic acid D (CAS#108340-60-9); Methyl ganoderate D (CAS#97210-12-3); 12-Hydroxyganoderic acid D (CAS#942950-96-1); 12-Acetoxy ganoderic acid D (CAS#N/A); Ganoderic acid M (CAS#100761-17-9); Ganoderic acid Z (CAS#294674-09-2); Ganoderic acid AM1 (CAS#149507-55-1); Ethyl ganoderate J (CAS#1189555-95-0); Methyl ganoderate E (CAS#98718-43-5).
Those compounds are series compounds, which having the similar structure but only some different in the individual atoms, functional groups and substructures. Maybe they also have the different physicochemical property, bioactivity and pharmacological property. In the drug design and reserach, they play an important role of improving the success rate of drug screening, researching of drug toxicity and acquiring of other data.
